The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Oxford Immunotex Global PLC | COM | G6855A103 | 35,127 | 2,579,062 | SH | DFND | 0 | 2,579,062 | 0 | 0 | |
| Neothetics, Inc. | COM | 64066G101 | 8,014 | 1,071,429 | SH | DFND | 0 | 1,071,429 | 0 | 0 | |
| Sientra Inc. | COM | 82621J105 | 45,849 | 2,730,765 | SH | DFND | 0 | 2,730,765 | 0 | 0 | |
| Nanostring Technologies Inc. | COM | 63009R109 | 55,155 | 3,959,440 | SH | DFND | 0 | 3,959,440 | 0 | 0 | |
| Ophthotech Corp | COM | 683745103 | 69,761 | 1,554,744 | SH | DFND | 0 | 1,554,744 | 0 | 0 | |
| Aerie Pharmaceuticals Inc. | COM | 00771V108 | 97,438 | 3,338,067 | SH | DFND | 0 | 3,338,067 | 0 | 0 | |
| TetraLogic Pharmaceuticals Corporation | COM | 88165U109 | 22,387 | 4,644,705 | SH | DFND | 0 | 4,644,705 | 0 | 0 | |
| VBI Vaccines Inc. | COM | 91790E102 | 16,554 | 4,971,091 | SH | DFND | 0 | 4,971,091 | 0 | 0 | |